New experimental antibiotics developed by chemists at the University of Connecticut successfully treat methicillin-resistant Staphylococcus aureus (MRSA) infections. The success is due to their strategy, which found a weakness and exploited it in a way the bacteria should have trouble countering. Stephanie M. Reeve et al. identified two plasmid-borne genes that confer high-level resistance to trimethoprim for the first time in MRSA isolates from U.S....
